|
Volumn 22, Issue 1, 2012, Pages 504-507
|
Identification of oxazolidinediones and thiazolidinediones as potent 17β-hydroxysteroid dehydrogenase type 3 inhibitors
|
Author keywords
17 Hydroxysteroid dehydrogenase type 3 inhibitors; Oxazolidinedione; Prostate cancer; Thiazolidinedione
|
Indexed keywords
17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 3;
2,4 THIAZOLIDINEDIONE DERIVATIVE;
5 (3 BROMO 4 HYDROXYBENZYL) 3 (4 METHOXYPHENYL) 1,3 THIAZOL 2 ONE;
5 (3 BROMO 4 HYDROXYBENZYLIDENE) 3 (4 METHOXYPHENYL) 2 THIOXO 1,3 THIAZOLIDIN 4 ONE;
ANDROGEN RECEPTOR;
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
ESTROGEN RECEPTOR ALPHA;
GLUCOCORTICOID RECEPTOR;
ISOENZYME;
OXAZOLIDINEDIONE DERIVATIVE;
RHODAMINE;
TESTOSTERONE 17BETA DEHYDROGENASE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BIOLOGICAL ACTIVITY;
ENZYME INHIBITION;
HIGH THROUGHPUT SCREENING;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
PROSTATE CANCER;
STRUCTURE ACTIVITY RELATION;
17-HYDROXYSTEROID DEHYDROGENASES;
CARBON;
CELL NUCLEUS;
CHEMISTRY, PHARMACEUTICAL;
DRUG DESIGN;
ENZYME INHIBITORS;
GENES, REPORTER;
HELA CELLS;
HUMANS;
INHIBITORY CONCENTRATION 50;
ISOENZYMES;
MALE;
MODELS, CHEMICAL;
MODELS, MOLECULAR;
MOLECULAR CONFORMATION;
OXAZOLES;
PROSTATE;
PROSTATIC NEOPLASMS;
THIAZOLIDINEDIONES;
|
EID: 84655165018
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.10.095 Document Type: Article |
Times cited : (22)
|
References (18)
|